Argen X Se Adr (ARGX)

Dec 18, 2025

BofA Securities raises argenx stock price target to $1,006 on strong Vyvgart outlook - Investing.com India

Dec 18, 2025

Dec 18, 2025

Baird downgrades argenx stock rating to Neutral on valuation concerns - Investing.com

Dec 18, 2025

Dec 17, 2025

Argenx stock price target raised to $925 from $860 at RBC Capital - Investing.com

Dec 17, 2025

Dec 15, 2025

Argenx stock rating maintained at Buy by BofA despite TED trial failure - Investing.com South Africa

Dec 15, 2025

Dec 15, 2025

Jefferies maintains Buy rating on argenx stock despite failed TED trial - Investing.com

Dec 15, 2025

Dec 15, 2025

argenx stock rating reiterated at Buy by Guggenheim despite TED study halt - Investing.com South Africa

Dec 15, 2025

Dec 15, 2025

Argenx Halts Phase 3 Thyroid Eye Disease Trial, Peers Like Viridian Therapeutics To Benefit - Benzinga

Dec 15, 2025

Dec 15, 2025

Argenx Halts Phase 3 Thyroid Eye Disease Trial, Peers Like Viridian Therapeutics To Benefit - Sahm

Dec 15, 2025

Dec 15, 2025

Argenx, ServiceNow And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga

Dec 15, 2025

Dec 15, 2025

argenx stock tumbles after discontinuing thyroid eye disease studies - Investing.com

Dec 15, 2025

Dec 14, 2025

Argenx, Navan And 3 Stocks To Watch Heading Into Monday - Sahm

Dec 14, 2025

Dec 11, 2025

Stifel raises argenx stock price target to $1,248 on Vyvgart dominance By Investing.com - Investing.com South Africa

Dec 11, 2025

Dec 11, 2025

Stifel raises argenx stock price target to $1,248 on Vyvgart dominance - Investing.com India

Dec 11, 2025

Dec 09, 2025

Argenx price target raised to $910 from $800 at UBS on Vyvgart growth By Investing.com - Investing.com South Africa

Dec 09, 2025

Dec 09, 2025

Argenx price target raised to $910 from $800 at UBS on Vyvgart growth - Investing.com India

Dec 09, 2025

Dec 08, 2025

DoorDash Upgraded, Microsoft Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Dec 08, 2025

Dec 03, 2025

Argenx NV ADR stock hits all-time high at $934.62 - Investing.com India

Dec 03, 2025

Dec 03, 2025

Argenx NV ADR stock hits all-time high at $934.62 By Investing.com - Investing.com South Africa

Dec 03, 2025

Nov 28, 2025

If You Invested $1000 In argenx Stock 5 Years Ago, You Would Have This Much Today - Sahm

Nov 28, 2025

Nov 25, 2025

ClearBridge International Growth ADR ESG Portfolios Q3 2025 Commentary - Seeking Alpha

Nov 25, 2025

Nov 24, 2025

This Argenx Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Benzinga

Nov 24, 2025

Nov 19, 2025

Oppenheimer raises argenx stock price target to $1,040 on higher Vyvgart sales By Investing.com - Investing.com South Africa

Nov 19, 2025

Nov 19, 2025

Oppenheimer raises argenx stock price target to $1,040 on higher Vyvgart sales - Investing.com India

Nov 19, 2025

Nov 19, 2025

Quant Ratings Updated on 141 Stocks - InvestorPlace

Nov 19, 2025

Nov 18, 2025

Eli Lilly Upgraded, Chewy Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Nov 18, 2025

Nov 18, 2025

argenx Announces Results of Extraordinary General Meeting of Shareholders - Sahm

Nov 18, 2025

Nov 17, 2025

Argenx stock reaches all-time high at 915.55 USD By Investing.com - Investing.com Nigeria

Nov 17, 2025

Nov 17, 2025

Argenx stock reaches all-time high at 915.55 USD - Investing.com

Nov 17, 2025

Nov 17, 2025

Stocks Showing Improving Market Leadership: argenx ADR Earns 84 RS Rating - MSN

Nov 17, 2025

Nov 07, 2025

Argenx NV ADR stock hits all-time high of 855.68 USD - Investing.com Nigeria

Nov 07, 2025

Nov 06, 2025

Argenx NV ADR stock hits all-time high of 855.68 USD By Investing.com - Investing.com South Africa

Nov 06, 2025

Nov 06, 2025

Janus Henderson Global Life Sciences Fund Q3 2025 Commentary - Seeking Alpha

Nov 06, 2025

Nov 05, 2025

argenx Announces VYVGART SC Prefilled Syringe for Self-Injection in Chronic Inflammatory Demyelinating Polyneuropathy Authorized for Sale by Health Canada - Barchart.com

Nov 05, 2025

Nov 04, 2025

Halozyme Beats on Q3 Earnings & Revenues, Raises 2025 View - Finviz

Nov 04, 2025

Nov 04, 2025

Piper Sandler raises argenx stock price target to $930 on strong Vyvgart sales By Investing.com - Investing.com South Africa

Nov 04, 2025

Nov 04, 2025

Piper Sandler raises argenx stock price target to $930 on strong Vyvgart sales - Investing.com

Nov 04, 2025

Nov 03, 2025

Vyvgart Fuels Strong Growth for Argenx and Supports Developing Pipeline - Morningstar

Nov 03, 2025